As opposed to reduced TEX being beneficial in cancer, reduced TEX has been associated with disease progression and increased severity in some autoimmune diseases including systemic lupus erythematosus (SLE), antineutrophil cytoplasmic antibody-associated vasculitis, and type 1 diabetes (T1D) (8–11). The gene discussed is TEX46; the disease is cancer.